Related Experiment Video
Updated: Apr 14, 2026

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
Fetal and early neonatal interleukin-6 response
Claudio Chiesa1, Lucia Pacifico2, Fabio Natale2
1Institute of Translational Pharmacology, National Research Council, 00133 Rome, Italy.
Insights
Elevated fetal interleukin-6 (IL-6) indicates an inflammatory response, predicting neonatal complications like early-onset neonatal sepsis (EONS) and white matter injury (WMI). This review examines IL-6
Area of Science:
- Perinatal medicine
- Neonatology
- Immunology
Background:
- Systemic fetal cytokine response, marked by elevated interleukin-6 (IL-6), identified in 1998 as a risk factor for neonatal morbidity.
- IL-6 blood concentrations are increasingly studied as markers for fetal inflammatory response syndrome (FIRS), early-onset neonatal sepsis (EONS), and white matter injury (WMI).
Purpose of the Study:
- Critically review the biological functions of IL-6.
- Evaluate the evidence linking IL-6 to preterm birth, FIRS, and EONS.
- Assess IL-6's role in predicting neonatal outcomes, including WMI.
Main Methods:
- Literature review of studies on IL-6 in fetal and neonatal periods.
- Analysis of IL-6 reference intervals and dynamics.
- Evaluation of diagnostic accuracy studies for EONS using IL-6.
Main Results:
- IL-6 is a significant indicator of fetal inflammation and a predictor of neonatal morbid events.
- Evidence supports the association between IL-6, preterm birth, FIRS, and EONS.
- Recent studies highlight the link between fetal IL-6, EONS, and WMI.
Conclusions:
- IL-6 is a crucial biomarker in perinatal medicine for identifying inflammatory states and predicting adverse neonatal outcomes.
- Further research is needed to refine the diagnostic and prognostic utility of IL-6.
- Understanding IL-6 dynamics is essential for managing high-risk pregnancies and neonates.
Abstract:
In 1998, a systemic fetal cytokine response, defined as a plasma interleukin-6 (IL-6) value above 11 pg/mL, was reported to be a major independent risk factor for the subsequent development of neonatal morbid events even after adjustments for gestational age and other confounders. Since then, the body of literature investigating the use of blood concentrations of IL-6 as a hallmark of the fetal inflammatory response syndrome (FIRS), a diagnostic marker of early-onset neonatal sepsis (EONS) and a risk predictor of white matter injury (WMI), has grown rapidly. In this article, we critically review: IL-6 biological functions; current evidence on the association between IL-6, preterm birth, FIRS and EONS; IL-6 reference intervals and dynamics in the early neonatal period; IL-6 response during the immediate postnatal period and perinatal confounders; accuracy and completeness of IL-6 diagnostic studies for EONS (according to the Standards for Reporting of Diagnostic Accuracy statement); and recent breakthroughs in the association between fetal blood IL-6, EONS, and WMI.
More Related Videos
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
08:58Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025